FAZİLE NUR EKİNCİ AKDEMİR, MUSTAFA SITKI GÖZELER, Serkan YILDIRIM, Seda AŞKIN, Muhammet Bahaeddin DÖRTBUDAK, AHMET KIZILTUNÇ

The effect of ferulic acid against cisplatin-induced ototoxicity

Ototoxicity refers to cellular damage or functional disorder developing in the inner ear in association with any therapeutic agent or chemical substance. Cisplatin, one of these agents capable of causing ototoxicity, is a chemotherapeutic used in several malignancies. Ferulic acid (FA) is a phenolic acid with known anti-oxidative and anti-inflammatory properties. The purpose of this study was to perform a biochemical and histopathological investigation of the protective efficacy of FA against cisplatin-induced ototoxicity in rats. Twenty-four Wistar rats were used in this study. Animals were randomly assigned into four groups of six rats each. Rats in the control group received intraperitoneal injection of 1 ml salin for four consecutive days. Rats in the cisplatin group received a single intraperitoneal administration of 10 mg/kg cisplatin. Rats in the FA group received intraperitoneal FA at 100 mg/kg for four days, and rats in the cisplatin+FA group received intraperitoneal FA at 100 mg/ kg 1 h after administration of intraperitoneal cisplatin at 10 mg/kg, this procedure being performed for four consecutive days. Rats were sacrificed 24 h after the final drug administration. Cochlear tissues were removed for biochemical and histopathological analysis. MDA levels were significantly higher in cochlear tissues of the rats receiving cisplatin compared to the control group. MDA levels in rats receiving cisplatin and treated with FA were significantly lower than those in the cisplatin group. Activities of SOD and GPx decreased significantly in the cochleas of rats administered cisplatin compared to the control group. Both SOD and GPx activities were significantly higher in rats administered FA and cisplatin in combination compared to the cisplatin only. Histopathological evaluation of cochleas of the rats revealed significant protection of FA against cisplatin induced ototoxicity. This study, the first in the literature, shows that FA exhibits a protective effect against cisplatin-induced ototoxicity.

PDF

___

Kara M, Türkön H, Karaca T, et al. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model. Int J Pediatr Otorhinolaryngol. 2016;85:12-8.

Sagit M, Korkmaz F, Akcadag A, Somdas MA. Protective effect of thymoquinone against cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol. 2013;270:2231-7.

Salehi P, Akinpelu OV, Waissbluth S, et al. Attenuation of cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a guinea pig model. Otol Neurotol. 2014;35:1131-9.

Giordano P, Lorito G, Ciorba A, et al. Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model. Acta Otorhinolaryngol Ital. 2006;26:198-207.

Lynch ED, Gu R, Pierce C,et al. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. . Hear Res. 2005;201:81-9.

So H, Kim H, Kim Y et al. Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1. J Assoc Res Otolaryngol. 2008;9:290-306.

Roldan-Fidalgo A, Martín Saldaña S, Trinidad A, et al. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity. Exp Toxicol Pathol. 2016;68:197-204.

Bami E, Ozakpınar OB, Ozdemir-Kumral ZN, et al. Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats. Environ Toxicol Pharmacol. 2017;54:105-11.

Donald EP, William NV. Studies on the quantitative characterization of erythrocyte glutathione peroxidase. J. Lab. & Clin Med. 1967;70:158-69

Ohkawa H, Ohiski N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbutric acid reaction. Anal Biochem. 1979; 95:351-8.

Sun Yi, Larry W. Oberley, Yet al. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;3413:497-500

Yumusakhuylu AC, Yazici M, Sari M, et al. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol. 2012;76:404–8.

Yazici ZM, Meric A, Midi A, et al. Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract. Eur Arch Otorhinolaryngol. 2012;269:45-52

Doğan M, Polat H, Yaşar M, et al. Protective role of misoprostol against cisplatin-induced ototoxicity. Eur Arch Otorhinolaryngol. 2016;273:3685-92.

C. Mancuso, R. Santangelo. Ferulic acid: pharmacological and toxicological aspects, Food Chem. Toxicol. 2014; 65:185–95.

Zeni ALB, Camargo A, Dalmagro AP. Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice. Steroids. 2017;125:131-6.

Gu L, Cui X, Wei W, et al. Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss. Exp Cell Res. 2017.

Fetoni AR, Mancuso C, Eramo SL, et al. In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig. Neuroscience. 2010;169:1575-88.